Back to Authors

group, BRAVE study

A5000990114

Mayo Clinic

No affiliation available

Citations 2

Envisia Genomic Classifier Demonstrates Consistent Performance Across Gender, Age Group, and Smoking Status

TP26. TP026 DIAGNOSIS, ASSESSMENT, AND PROGNOSIS OF FIBROTIC ILD | May 4, 2021 | Volume: No volume available | Issue: No issue available | Pages: A1839-A1839

10.1164/ajrccm-conference.2021.203.1_meetingabstracts.a1839

Envisia Genomic Classifier Helps Improve Multidisciplinary Diagnoses of Complex Interstitial Lung Diseases

TP27. TP027 DIFFUSE PARENCHYMAL LUNG DISEASE: PATIENT CHARACTERISTICS AND OUTCOMES | May 4, 2021 | Volume: No volume available | Issue: No issue available | Pages: A1877-A1877

10.1164/ajrccm-conference.2021.203.1_meetingabstracts.a1877